General Information
Revision date
2017-03-29
Product name
LYSIS FIRST
Icons in SDS
Company Information
company name
SOFRALAB
e-mail address of the competent person responsible for the Safety Data Sheet
lcq@sofralab.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
2.1 Classification of the substance or mixture
EC regulation criteria 1272/2008 (CLP) Danger, Resp. Sens. 1, May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Adverse physicochemical, human health and environmental effects
No other hazards
Hazard pictograms
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P284 [In case of inadequate ventilation] wear respiratory protection. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor/... P501 Dispose of contents/container in accordance with applicable regulations.
Special Provisions
None
Contains
Pectinases
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
None
vPvB Substances
None
PBT Substances
None
Other hazards
No other hazards
